Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00102310
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2005-01-26
Brief Title:
YM443 in Subjects With Functional Dyspepsia
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Study Overview
Official Title:
A Phase 2b Multicenter Randomized Double-blind Placebo-Controlled Parallel Group Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status:
COMPLETED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study will be to characterize the dose response profile of YM443 in subjects with functional dyspepsia FD to enable the selection of doses for the Phase 3 clinical trial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None